Sutro Biopharma, Inc. (STRO)
STRO Stock Price Chart
Explore Sutro Biopharma, Inc. interactive price chart. Choose custom timeframes to analyze STRO price movements and trends.
STRO Company Profile
Discover essential business fundamentals and corporate details for Sutro Biopharma, Inc. (STRO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
27 Sept 2018
Employees
269.00
Website
https://www.sutrobio.comCEO
Jane Chung
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials. It has collaboration and license agreements with Merck Collaboration to develop research programs focusing on cytokine derivatives for cancer and autoimmune disorders; and Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.
STRO Financial Timeline
Browse a chronological timeline of Sutro Biopharma, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 11 Mar 2026
Upcoming earnings on 12 Nov 2025
EPS estimate is -$0.39.
Earnings released on 7 Aug 2025
EPS came in at -$0.14 surpassing the estimated -$0.39 by +64.10%, while revenue for the quarter reached $63.75M , beating expectations by +302.50%.
Earnings released on 8 May 2025
EPS came in at -$0.91 falling short of the estimated -$0.63 by -44.44%, while revenue for the quarter reached $17.40M , beating expectations by +15.99%.
Earnings released on 13 Mar 2025
EPS came in at -$0.89 falling short of the estimated -$0.86 by -3.49%, while revenue for the quarter reached $14.81M , beating expectations by +21.84%.
Earnings released on 13 Nov 2024
EPS came in at -$0.59 surpassing the estimated -$0.74 by +20.27%, while revenue for the quarter reached $8.52M , missing expectations by -30.06%.
Earnings released on 13 Aug 2024
EPS came in at -$0.59 surpassing the estimated -$0.76 by +22.37%, while revenue for the quarter reached $25.71M , beating expectations by +22.29%.
Earnings released on 13 May 2024
EPS came in at -$0.95 falling short of the estimated -$0.92 by -3.26%, while revenue for the quarter reached $13.01M , beating expectations by +9.13%.
Earnings released on 25 Mar 2024
EPS came in at $0.52 surpassing the estimated -$0.82 by +163.41%, while revenue for the quarter reached $113.72M , beating expectations by +862.92%.
Earnings released on 13 Nov 2023
EPS came in at -$0.81 falling short of the estimated -$0.76 by -6.58%, while revenue for the quarter reached $16.92M , beating expectations by +43.30%.
Earnings released on 10 Aug 2023
EPS came in at -$0.64 surpassing the estimated -$0.73 by +12.33%, while revenue for the quarter reached $10.41M , missing expectations by -17.10%.
Earnings released on 15 May 2023
EPS came in at -$0.76 surpassing the estimated -$0.83 by +8.43%, while revenue for the quarter reached $12.67M , beating expectations by +4.47%.
Earnings released on 30 Mar 2023
EPS came in at -$0.61 surpassing the estimated -$0.64 by +4.69%, while revenue for the quarter reached $8.63M , missing expectations by -22.58%.
Earnings released on 8 Nov 2022
EPS came in at -$0.37 falling short of the estimated -$0.15 by -146.67%, while revenue for the quarter reached $25.15M , missing expectations by -29.59%.
Earnings released on 8 Aug 2022
EPS came in at -$0.55 surpassing the estimated -$0.74 by +25.68%, while revenue for the quarter reached $28.10M , beating expectations by +75.54%.
Earnings released on 9 May 2022
EPS came in at -$0.84 falling short of the estimated -$0.79 by -6.33%, while revenue for the quarter reached $5.90M , missing expectations by -43.62%.
Earnings released on 28 Feb 2022
EPS came in at -$0.83 falling short of the estimated -$0.67 by -23.88%, while revenue for the quarter reached $10.65M , missing expectations by -9.81%.
Earnings released on 10 Nov 2021
EPS came in at -$0.67 matching the estimated -$0.67, while revenue for the quarter reached $8.52M , meeting expectations.
Earnings released on 9 Aug 2021
EPS came in at -$0.13 surpassing the estimated -$0.42 by +69.05%, while revenue for the quarter reached $28.05M , meeting expectations.
Earnings released on 7 May 2021
EPS came in at -$0.43 surpassing the estimated -$0.61 by +29.51%, while revenue for the quarter reached $14.66M , beating expectations by +11.11%.
Earnings released on 18 Mar 2021
EPS came in at -$1.48 falling short of the estimated -$0.56 by -164.29%, while revenue for the quarter reached $8.28M .
Earnings released on 5 Nov 2020
EPS came in at -$0.33 surpassing the estimated -$0.44 by +25.00%, while revenue for the quarter reached $17.82M .
STRO Stock Performance
Access detailed STRO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.